The mechanisms of aspirin-intolerant asthma and its management.

被引：9

作者：

McGeehan M. ^{[1
]}

Bush R.K. ^{[1
]}

机构：

[1] Department of Medicine, University of Wisconsin-Madison, 600 Highland Avenue, Madison, 53792, WI

来源：

Current Allergy and Asthma Reports | 2002年 / 2卷 / 2期

关键词：

Asthma; Aspirin; Allergy Clin Immunol; Nasal Polyp; Tiaprofenic Acid;

D O I：

10.1007/s11882-002-0006-1

中图分类号：

学科分类号：

摘要：

Aspirin is one of the most widely used medications in the world. Adverse effects related to aspirin use were described almost concurrently with its first use. The most common side effects are gastrointestinal and renal, but adverse respiratory effects are not uncommon, and approximately 10% of adult asthmatics are aspirin intolerant. Many of these patients present with the so-called aspirin triad of aspirin sensitivity, chronic rhinosinusitis with associated nasal polyposis, and severe asthma. This paper provides a review of recent investigations into the pathogenesis of this process, which have furthered our understanding of the mechanisms and management of aspirin-induced asthma.

引用

页码：117 / 125

页数：8

共 161 条

[21]

Szczeklik A(2001)Safety of a specific COX-2 inhibitor in aspirin-induced asthma Clin Exp Allergy 31 219-225

[22]

Nizankowska E(1977)Aspirin-sensitive asthma: the effect of aspirin on the release of prostaglandins from nasal polyps Pharmacol Res Commun 9 415-425

[23]

Duplaga M(1999)Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirinsensitive asthmatics Am J Respir Crit Care Med 160 291-296

[24]

Ameisen JC(2000)Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients Am J Respir Crit Care Med 161 391-398

[25]

Capron A(2000)Aspirin and asthma Chest 118 1470-1476

[26]

Pleskow WW(1992)Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics Am Rev Respir Dis 146 96-103

[27]

Chenoweth DE(1999)Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses J Allergy Clin Immunol 104 559-564

[28]

Simon RA(1992)Increased excretion of leukotriene E4 during aspirin-induced asthma J Lab Clin Med 119 48-51

[29]

Szczeklik A(1991)Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects Am Rev Respir Dis 143 1025-1029

[30]

Restivo C(1996)Bronchial aspirin challenge causes specific eicosanoid response in aspirinsensitive asthmatics Am J Respir Crit Care Med 154 1608-1614

← 1 2 3 4 5 6 7 8 9 10 →